FDA Ad Division Reorganization Splits Review Of Professional, DTC Materials
Executive Summary
FDA's Division of Drug Marketing, Advertising & Communications is reorganizing its enforcement and review staff into health professional and consumer review groups
You may also be interested in...
FDA Ad Division Will Increase Focus On Outcomes Claims After Reorganization
FDA's reorganized Division of Drug Marketing, Advertising & Communication will be increasing its focus on promotions based on outcomes data, Division Director Tom Abrams said during the Drug Information Association's annual meeting in Chicago June 18
FDA Ad Division Will Increase Focus On Outcomes Claims After Reorganization
FDA's reorganized Division of Drug Marketing, Advertising & Communication will be increasing its focus on promotions based on outcomes data, Division Director Tom Abrams said during the Drug Information Association's annual meeting in Chicago June 18
FDA regulatory counsel
Center for Drug Evaluation & Research is recruiting a second regulatory counsel for the Division of Drug Marketing, Advertising & Communications. FDA's ad division said it requires additional legal counsel in order to support enforcement actions responding to the entire marketplace, including exhibit hall and Internet promotion. The Bush Administration's hiring freeze will temporarily prevent FDA from completing the hire. FDA is not currently looking to fill the ad division's deputy director position, which has remained vacant since Tom Abrams became permanent director of the division in February 2000 (1"The Pink Sheet" Feb. 21, 2000, p. 29)